Literature DB >> 22354293

Phytosphingosine-1-phosphate is a signaling molecule involved in miconazole resistance in sessile Candida albicans cells.

Davy Vandenbosch1, Anna Bink, Gilmer Govaert, Bruno P A Cammue, Hans J Nelis, Karin Thevissen, Tom Coenye.   

Abstract

Previous research has shown that 1% to 10% of sessile Candida albicans cells survive treatment with high doses of miconazole (a fungicidal imidazole). In the present study, we investigated the involvement of sphingolipid biosynthetic intermediates in this survival. We observed that the LCB4 gene, coding for the enzyme that catalyzes the phosphorylation of dihydrosphingosine and phytosphingosine, is important in governing the miconazole resistance of sessile Saccharomyces cerevisiae and C. albicans cells. The addition of 10 nM phytosphingosine-1-phosphate (PHS-1-P) drastically reduced the intracellular miconazole concentration and significantly increased the miconazole resistance of a hypersusceptible C. albicans heterozygous LCB4/lcb4 mutant, indicating a protective effect of PHS-1-P against miconazole-induced cell death in sessile cells. At this concentration of PHS-1-P, we did not observe any effect on the fluidity of the cytoplasmic membrane. The protective effect of PHS-1-P was not observed when the efflux pumps were inhibited or when tested in a mutant without functional efflux systems. Also, the addition of PHS-1-P during miconazole treatment increased the expression levels of genes coding for efflux pumps, leading to the hypothesis that PHS-1-P acts as a signaling molecule and enhances the efflux of miconazole in sessile C. albicans cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22354293      PMCID: PMC3346612          DOI: 10.1128/AAC.05106-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Accumulation of phosphorylated sphingoid long chain bases results in cell growth inhibition in Saccharomyces cerevisiae.

Authors:  S Kim; H Fyrst; J Saba
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

Review 2.  An overview of sphingolipid metabolism: from synthesis to breakdown.

Authors:  Christopher R Gault; Lina M Obeid; Yusuf A Hannun
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin.

Authors:  Y Miyake; Y Kozutsumi; S Nakamura; T Fujita; T Kawasaki
Journal:  Biochem Biophys Res Commun       Date:  1995-06-15       Impact factor: 3.575

4.  Elevation of endogenous sphingolipid long-chain base phosphates kills Saccharomyces cerevisiae cells.

Authors:  X Zhang; M S Skrzypek; R L Lester; R C Dickson
Journal:  Curr Genet       Date:  2001-12       Impact factor: 3.886

5.  Lipid rafts in protein sorting and cell polarity in budding yeast Saccharomyces cerevisiae.

Authors:  Michel Bagnat; Kai Simons
Journal:  Biol Chem       Date:  2002-10       Impact factor: 3.915

6.  Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect.

Authors:  Daisuke Kobayashi; Kei Kondo; Nobuyuki Uehara; Seiko Otokozawa; Naoki Tsuji; Atsuhito Yagihashi; Naoki Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

7.  Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.

Authors:  Hanadi Lamfon; Stephen R Porter; Michael McCullough; Jonathan Pratten
Journal:  J Antimicrob Chemother       Date:  2004-01-16       Impact factor: 5.790

8.  Differences in membrane fluidity and fatty acid composition between phenotypic variants of Streptococcus pneumoniae.

Authors:  Barak Aricha; Itzhak Fishov; Zvi Cohen; Noga Sikron; Stella Pesakhov; Inna Khozin-Goldberg; Ron Dagan; Nurith Porat
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

Review 9.  Cytochrome P450 of fungi: primary target for azole antifungal agents.

Authors:  Y Yoshida
Journal:  Curr Top Med Mycol       Date:  1988

10.  Biofilm formation by Candida species on the surface of catheter materials in vitro.

Authors:  S P Hawser; L J Douglas
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

View more
  2 in total

1.  Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans.

Authors:  Kevin Kim; Leeor Zilbermintz; Mikhail Martchenko
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-06-09       Impact factor: 3.944

2.  Unmasking of CgYor1-Dependent Azole Resistance Mediated by Target of Rapamycin (TOR) and Calcineurin Signaling in Candida glabrata.

Authors:  Sonam Kumari; Mohit Kumar; Brooke D Esquivel; Mohd Wasi; Ajay Kumar Pandey; Nitesh Kumar Khandelwal; Alok K Mondal; Theodore C White; Rajendra Prasad; Naseem A Gaur
Journal:  mBio       Date:  2022-01-18       Impact factor: 7.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.